Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rustenburg Platinum Mines is a major South African mining company and a primary producer of platinum group metals (PGMs), including platinum, palladium, and rhodium. While the company is fundamentally a mining and metallurgical operation, it serves as a critical upstream provider for the healthcare and life sciences sectors. Its PGM products are essential raw materials for the production of platinum-based chemotherapy agents such as cisplatin, carboplatin, and oxaliplatin. Furthermore, the company's metals are utilized in the manufacturing of high-precision medical devices, including pacemakers, stents, and surgical instruments. Historically a core part of Anglo American Platinum, the Rustenburg operations were sold to Sibanye-Stillwater in 2016, though the entity remains a cornerstone of the global PGM supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rustenburg Platinum Group.